UPC Case Law
Meril Italy S.r.l. v SWAT Medical AB and another
Order of the UPC Court of Appeal of 12 February 2025, UPC CoA 634/2024
UPC Case Law by Pitch, edited by Bart Lieben · Published
TL;DR
A lawyer or European Patent Attorney who is personally a party before the UPC cannot represent themselves. A company cannot be represented by the chair of its board, even one qualified to act before the UPC. The Court of Appeal raised representation of its own motion, but exceptionally gave the applicants for register access 14 days to appoint proper representatives and lodge a Statement of response.
Key holding
Under R 8.1 RoP and Art 48 UPCA, lawyers and European Patent Attorneys are not exempted from the duty to be represented if they themselves are parties in cases before the UPC. A natural person with extensive administrative and financial powers in a legal person, such as the chair of its board of directors, cannot represent that legal person, whatever their UPC qualification. Representation is a point of admissibility involving public policy (due process) which the Court may examine at any time, of its own motion.
Questions decided
- May a European Patent Attorney who is a party represent himself before the UPC?
- May the chair of a company's board represent that company before the UPC?
- Is an inadmissibility objection first raised after the grounds of appeal admissible?
- May the Court examine representation of its own motion at any time?
- When will the Court allow a party time to appoint a representative?
Full summary
Read the full analyses for free — create a free account
With a free Academy account you read the full analysis of every Court of Appeal decision: the facts and procedure, the issues, the court’s reasoning and the practice points. Your name, an e-mail address and a password; no payment, and you can delete the account yourself at any time.
In the same case
- Decision · UPC CoA 464/2024
Meril Italy Srl and others v Edwards Lifesciences Corporation
The Court of Appeal upheld EP 3 646 825 as amended by Auxiliary Request II and confirmed that Meril's Myval Octacor heart valve system infringes it.
- Order · UPC CoA 166/2025
Meril GmbH and others v Edwards Lifesciences Corporation
The Court of Appeal refused Meril's request to suspend the Munich Local Division's infringement decision in favour of Edwards Lifesciences pending Meril's appeal.
More on procedure
- Decision · UPC CoA 163/2026
PAUSTIAN & PARTNER Patentanwälte mbB v NUC Electronics Europe GmbH and others
The Court of Appeal granted a patent law firm access to the statements of appeal and statements of grounds of appeal in three closed appeals concerning EP 2 028 981.
- Order · UPC CoA 133/2026
The Walt Disney Company and others v InterDigital VC Holdings, Inc.
A request under R 262A RoP to stop the other party from accessing or using confidential information cannot be made for the first time on appeal for material already filed at first instance.
- Decision · UPC CoA 49/2026
Guardant Health, Inc. v Sophia Genetics SA and others
The Court of Appeal set aside a EUR 600,000 award of representation costs because the successful party had backed it only with invoices reading "supply of legal services" and general assertions about complexity and urgency.
- Order · UPC CoA 176/2026
Netflix Services Germany GmbH and others v DivX, LLC
The Court of Appeal refused Netflix's request for suspensive effect against the Munich Local Division's infringement decision in favour of DivX, even though the EPO Opposition Division revoked the patent after that decision.